Pharma industry in India.

Globally ranked fourth by volume and 13th in value, the Indian pharma industry is a leading producer of high-quality, low-cost generic drugs. Its 14% share of the USD 57 billion world generic market is expected to increase to 50% by 2010. With the advantages of cost competitiveness, ability and experience in reverse engineering, availability of skilled scientific and engineering personnel and the capability to produce raw materials for a wide range of drugs from the basic stage, the industry delivers the entire range of therapeutic products. McKinsey & Co. predict that India's pharmaceutical market could reach a size of USD 20 billion by 2015, becoming one of the top 10 drug markets in the world. Generic versions of the cardiovascular drug carvedilol, ANDA-approved allopurinol, verapamil SR and the anticancer drug paclitaxel are some of the recent products introduced by Indian companies, with Caraco, Ranbaxy, Dabur, Dr. Reddy's, Nicholas Piramal India, leading the list. Setting up of integrated drug development companies and aggressive entries into the Japanese drug market have provided further impetus to the country's pharma manufacturing arena.

Congenital indifference to pain.

Congenital analgesia can vary from simple analgesia without any systemic dysfunction to more serious conditions associated with peripheral neuropathy, self-mutilation, and mental retardation. Prevention of injury is important for normal growth of the child.

Planned parenthood and childcare.

PIP: It is well known that couples, especially in lower income groups in India, will more readily accept family planning, especially permanent sterilization, if they are assured that their existing children will survive. Therefore, a successful family planning program in India must be linked with a comprehensive maternal and child care system. A study was undertaken among 71 low income couples in Madras, India, who had undergone voluntary sterilization for contraceptive purposes at least 1 year previously. The morbidity, mortality, and immunization status in the children of the sterilized families were no different from general statistics for the pediatric poulation as a whole. It is recommended that an effective child care system for these children will be the best incentive for motivation of the general community to accept family planning. There should be coordinated planning between the family planning and pediatric de0artments in the national health system. The work of all agencies involved in child care should be coordinated.^ieng